Name of pathway | Count | p-value | Fold enrichment | FDR |
---|---|---|---|---|
CCGs | ||||
Oxidative phosphorylation | 22 | 3.18E−19 | 12.11 | 2.62E−14 |
*Parkinson’s disease | 21 | 2.63E−17 | 10.82 | 1.81E−12 |
Alzheimer’s disease | 22 | 4.60E−17 | 9.58 | 3.75E−12 |
*Non-alcoholic fatty liver disease (NAFLD) | 21 | 1.12E−14 | 8.00 | 6.41E−10 |
Huntington’s disease | 19 | 2.72E−14 | 9.21 | 1.05E−09 |
Metabolic pathways | 41 | 7.24E−12 | 2.52 | 3.04E−06 |
ICGs | ||||
Vitamin digestion and absorption | 8 | 1.22E−7 | 18.53 | 1.52E−04 |
Fat digestion and absorption | 41 | 3.57E−4 | 1.71 | 0.4450 |
Protein digestion and absorption | 6 | 8.80E−4 | 7.84 | 1.0931 |
Metabolic pathways | 8 | 1.63E−3 | 4.63 | 1.9248 |
Chemical carcinogenesis | 7 | 4.53E−3 | 4.46 | 5.4888 |